Quality of life of patients with actinic keratoses and/or a superficial basal cell carcinoma treated with Imiquimod 5% cream.

• Conditions: patients with actinic keratoses and/or a superficial basal cell carcinoma; MedDRA version: 9.1Level: LLTClassification code 10042503Term: Superficial basal cell carcinoma; MedDRA version: 9.1Level: LLTClassification code 10000614Term: Actinic keratosis

• Registration Number: EUCTR2008-002501-39-NL
• Lead Sponsor: MedaPharma

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-10-30
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

patient with actinic keratoses and/or a superficial basal cell carcinoma
patient has to be able to treat him/herself with the cream, or has someone who can do that for them.
patient has to be older than 18 years
a signed informed consent by the patient
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

patients who are mentally or physically not capable to fill out the questionnaires and the diary
patients who are not able to speak Dutch in a way they need to fill out the questionnaires and diary.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified